Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK1 | Q13153 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4582925 | 0.97 | PAK1 (0.57) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4584207 | 0.96 | CYP1A2 (0.56) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4582847 | 0.90 | CYP1A2 (0.52) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4583131 | 0.88 | PDGFRB (0.53) | PAK1CYP1A2CYP2D6PDGFRBALDH1A1 | |
| SCHEMBL4582263 | 0.88 | CYP1A2 (0.49) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4583185 | 0.88 | CYP1A2 (0.49) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4584940 | 0.87 | CYP1A2 (0.54) | PAK1CYP1A2CYP2D6CYP3A4CYP2C19 | |
| SCHEMBL4726373 | 0.86 | CYP1A2 (0.46) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4728704 | 0.86 | EGFR (0.46) | PAK1CYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL4583789 | 0.85 | PAK1 (0.49) | PAK1CYP1A2CYP2D6KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008028690-A1 | 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |